Akira Yamauchi

1 ta ish

Kitano Hospital, Department of Breast Surgery, Osaka, Japan,

1. 1141 Clinical Use of HER2 Extracellular Domain as a Marker to Monitor Cancer Status and Predict the Response to Anti-cancer Treatment in Breast Cancer

   Keiichi Kontani, S. Hashimoto, Chisa Murazawa +4

   MaqolaHER2/EGFR in Cancer ResearchEuropean Journal of Cancer20120 iqtibos

   ABIABI:AkademIndex/openalex/2012.article.000368